
Startup accelerator and early-stage investor running intensive batches for new technology founders

Early-stage life sciences fund backing therapeutics, medical device and diagnostics companies

Pathway Bioventures is an early-stage venture fund for life sciences. It invests in precision therapeutics, medical devices and diagnostics businesses that tackle unmet medical needs. The firm looks for technology where biology and engineering meet.
Entrepreneurs working on advances in human health. Its site highlights portfolio news, including a collaboration between one investee and a large drug maker and the acquisition of another by a pharmaceutical company.
Summary written by TrustList from the business's own published information, Oct 2026.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Pathway Bioventures.
Similar listings buyers compare against this one.

Startup accelerator and early-stage investor running intensive batches for new technology founders

Venture capital firm backing pre-seed deep technology startups in health and planetary sustainability

Silicon Valley venture capital firm investing from seed to growth stage across technology sectors

Global venture capital firm and accelerator backing early-stage technology founders, formerly called 500 Startups

A community-driven venture network supporting entrepreneurs building in the crypto and decentralised technology space

A Latin America-focused early-stage venture capital fund investing in fintech and blockchain

Dutch seed fund that creates and builds high-tech start-ups from university and research institute technology

Venture capital firm investing in founders building new technology, including defence tech and AI for the physical world
Everything here links back to the same verified catalogue. Pick your next stop.